BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty has maintained a Market Perform rating on Ingevity (NYSE:NGVT) and lowered the price target from $54 to $43.
November 09, 2023 | 7:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ingevity's price target has been lowered from $54 to $43 by BMO Capital, while maintaining a Market Perform rating.
The lowering of the price target by BMO Capital indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Ingevity's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100